TY - JOUR
T1 - Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction
AU - Hashimoto, Masahito
AU - Furuyashiki, Maiko
AU - Kaseya, Ryoko
AU - Fukada, Yuka
AU - Akimaru, Mai
AU - Aoyama, Kazue
AU - Okuno, Toshiomi
AU - Tamura, Toshihide
AU - Kirikae, Teruo
AU - Kirikae, Fumiko
AU - Eiraku, Nobutaka
AU - Morioka, Hirofumi
AU - Fujimoto, Yukari
AU - Fukase, Koichi
AU - Takashige, Katsuhiro
AU - Moriya, Yoichiro
AU - Kusumoto, Shoichi
AU - Suda, Yasuo
PY - 2007/4
Y1 - 2007/4
N2 - Lipoteichoic acid (LTA) is a cell surface glycoconjugate of gram-positive bacteria and is reported to activate the innate immune system. We previously reported that purified LTA obtained from Enterococcus hirae has no immunostimulating activity, but a subfraction (Eh-AF) in an LTA fraction possesses activity. In this study, we established a mouse monoclonal antibody neutralizing the activity of Eh-AF and investigated its inhibitory effects. Monoclonal antibody (MAbEh1) was established by the immunization of BALB/c mice with Eh-AF, followed by hybridoma screening based on its inhibitory effect for the production of interleukin-6 (IL-6) induced by Eh-AF. MAbEh1 neutralized the production of IL-6 by LTA fraction from not only E. hirae but also Staphylococcus aureus, while it failed to block that of lipopolysaccharide, suggesting that the antibody recognized a common active structure(s) in LTA fractions. Synthetic glycolipids in these LTAs did not induce cytokine production, at least in our system. Interestingly, the antibody was found to inhibit the activity of immunostimulating synthetic lipopeptides, Pam 3CSK4 and FSL-1. These results suggest that MAbEh1 neutralizes the activity of lipoprotein-like compounds which is responsible for the activity of the LTA fraction of E. hirae and S. aureus.
AB - Lipoteichoic acid (LTA) is a cell surface glycoconjugate of gram-positive bacteria and is reported to activate the innate immune system. We previously reported that purified LTA obtained from Enterococcus hirae has no immunostimulating activity, but a subfraction (Eh-AF) in an LTA fraction possesses activity. In this study, we established a mouse monoclonal antibody neutralizing the activity of Eh-AF and investigated its inhibitory effects. Monoclonal antibody (MAbEh1) was established by the immunization of BALB/c mice with Eh-AF, followed by hybridoma screening based on its inhibitory effect for the production of interleukin-6 (IL-6) induced by Eh-AF. MAbEh1 neutralized the production of IL-6 by LTA fraction from not only E. hirae but also Staphylococcus aureus, while it failed to block that of lipopolysaccharide, suggesting that the antibody recognized a common active structure(s) in LTA fractions. Synthetic glycolipids in these LTAs did not induce cytokine production, at least in our system. Interestingly, the antibody was found to inhibit the activity of immunostimulating synthetic lipopeptides, Pam 3CSK4 and FSL-1. These results suggest that MAbEh1 neutralizes the activity of lipoprotein-like compounds which is responsible for the activity of the LTA fraction of E. hirae and S. aureus.
UR - http://www.scopus.com/inward/record.url?scp=34147097437&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34147097437&partnerID=8YFLogxK
U2 - 10.1128/IAI.02083-05
DO - 10.1128/IAI.02083-05
M3 - Article
C2 - 17283098
AN - SCOPUS:34147097437
SN - 0019-9567
VL - 75
SP - 1926
EP - 1932
JO - Infection and Immunity
JF - Infection and Immunity
IS - 4
ER -